CA2328138A1 - A novel method of diagnosing, monitoring, and staging lung cancer - Google Patents
A novel method of diagnosing, monitoring, and staging lung cancer Download PDFInfo
- Publication number
- CA2328138A1 CA2328138A1 CA002328138A CA2328138A CA2328138A1 CA 2328138 A1 CA2328138 A1 CA 2328138A1 CA 002328138 A CA002328138 A CA 002328138A CA 2328138 A CA2328138 A CA 2328138A CA 2328138 A1 CA2328138 A1 CA 2328138A1
- Authority
- CA
- Canada
- Prior art keywords
- lsg
- levels
- cancer
- lung
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8621298P | 1998-05-21 | 1998-05-21 | |
US60/086,212 | 1998-05-21 | ||
PCT/US1999/010344 WO1999060160A1 (en) | 1998-05-21 | 1999-05-12 | A novel method of diagnosing, monitoring, and staging lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2328138A1 true CA2328138A1 (en) | 1999-11-25 |
Family
ID=22197037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002328138A Abandoned CA2328138A1 (en) | 1998-05-21 | 1999-05-12 | A novel method of diagnosing, monitoring, and staging lung cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1082459A4 (de) |
JP (1) | JP3688585B2 (de) |
CA (1) | CA2328138A1 (de) |
WO (1) | WO1999060160A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7291712B2 (en) | 1998-06-25 | 2007-11-06 | Genentech, Inc. | Interleukin-8 homologous polypeptides and therapeutic uses thereof |
JP3524061B2 (ja) * | 1998-08-04 | 2004-04-26 | ダイアデクスアス・インコーポレーテッド | 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法 |
PT1109937E (pt) * | 1998-09-02 | 2009-02-10 | Diadexus Inc | Um novo método de diagnóstico, monitorização, identificação de estágio, imagiologia e tratamento de vários cancros |
US20020004206A1 (en) * | 1999-04-09 | 2002-01-10 | Berger Barry M. | Methods of screening for disease |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2001053349A2 (en) * | 2000-01-21 | 2001-07-26 | Ludwig Institute For Cancer Research | Small cell lung cancer associated antigens and uses therefor |
WO2001061055A2 (en) * | 2000-02-17 | 2001-08-23 | Diadexus, Inc. | Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
AU2001251084A1 (en) * | 2000-03-29 | 2001-10-08 | Diadexus, Inc. | Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
WO2002008278A2 (en) * | 2000-07-21 | 2002-01-31 | Diadexus, Inc. | Compositions and methods relating to lung specific genes |
EP1328635A2 (de) * | 2000-08-28 | 2003-07-23 | Diadexus, Inc. | Zusammensetzungen und verfahren mit bezug zu lungenspezifischen genen |
WO2002077236A2 (en) * | 2000-10-26 | 2002-10-03 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
WO2002068633A2 (en) * | 2000-11-22 | 2002-09-06 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
EP1873245A1 (de) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Interleukin-8-homologe Polypeptide und ihre therapeutische Verwendung |
CA2456334A1 (en) | 2001-08-16 | 2003-02-27 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Molecular characteristics of non-small cell lung cancer |
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
WO2006013012A2 (en) * | 2004-08-04 | 2006-02-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with napsin 1 (nap1) |
US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
EP3770278A1 (de) | 2005-04-14 | 2021-01-27 | The Trustees of Boston University | Diagnose für lungenerkrankungen mittels klassenvorhersage |
US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
EP2605018A1 (de) | 2006-03-09 | 2013-06-19 | The Trustees of the Boston University | Diagnose- und Prognoseverfahren für Lungenerkrankungen mittels Genexpressionsprofilen aus Nasenepithelzellen |
US20090186951A1 (en) | 2007-09-19 | 2009-07-23 | Brody Jerome S | Identification of novel pathways for drug development for lung disease |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
WO2014186036A1 (en) | 2013-03-14 | 2014-11-20 | Allegro Diagnostics Corp. | Methods for evaluating copd status |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
EP3770274A1 (de) | 2014-11-05 | 2021-01-27 | Veracyte, Inc. | Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten |
US10927417B2 (en) | 2016-07-08 | 2021-02-23 | Trustees Of Boston University | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2221798A1 (en) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Colon specific genes and proteins |
WO1998020143A1 (en) * | 1996-11-05 | 1998-05-14 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
JP2001522225A (ja) * | 1997-01-31 | 2001-11-13 | アボツト・ラボラトリーズ | 肺の疾患の検出に有用な試薬及び方法 |
US6203979B1 (en) * | 1998-01-16 | 2001-03-20 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
CA2331386A1 (en) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
-
1999
- 1999-05-12 CA CA002328138A patent/CA2328138A1/en not_active Abandoned
- 1999-05-12 JP JP2000549766A patent/JP3688585B2/ja not_active Expired - Fee Related
- 1999-05-12 EP EP99921894A patent/EP1082459A4/de not_active Withdrawn
- 1999-05-12 WO PCT/US1999/010344 patent/WO1999060160A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002515262A (ja) | 2002-05-28 |
WO1999060160A1 (en) | 1999-11-25 |
EP1082459A1 (de) | 2001-03-14 |
JP3688585B2 (ja) | 2005-08-31 |
EP1082459A4 (de) | 2002-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2328138A1 (en) | A novel method of diagnosing, monitoring, and staging lung cancer | |
CN107326066B (zh) | 用于膀胱癌检测的尿标记物 | |
EP1080227B1 (de) | Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs | |
EP2430193B1 (de) | Marker für den nachweis von magenkrebs | |
CA2341142A1 (en) | A novel method of diagnosing, monitoring, staging, imaging and treating various cancers | |
US20060035292A1 (en) | Differential diagnosis of cancer and other conditions based on expression of p63 | |
US6228596B1 (en) | Method of detecting and monitoring endometrial and uterine cancers | |
EP1270745A2 (de) | Thymosin B15 als Marker in der Diagnosis und Prognose von Krebs | |
JP3524061B2 (ja) | 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法 | |
JP3677210B2 (ja) | 前立腺がんを診断し、モニターし、そして病期決定する新規な方法 | |
JP2002525031A (ja) | 大腸癌の診断、監視、病期決定、画像処理及び治療の新規方法 | |
US7713693B1 (en) | Human cancer cell specific gene transcript | |
US6949339B1 (en) | Method of diagnosing, monitoring, and staging colon cancer | |
US7160679B1 (en) | Method of diagnosing, monitoring, and staging lung cancer | |
US6861215B1 (en) | Method of diagnosing, monitoring, and staging prostate cancer | |
JP2002526760A (ja) | 消化器癌を診断、監視、病期分類、イメージング及び治療する新規な方法 | |
JP2002526055A (ja) | 婦人科癌及び精巣癌を診断、監視、病期分類、イメージング及び治療する方法 | |
US6379893B1 (en) | Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies | |
EP1621639A2 (de) | Neuartiges Verfahren zur Diagnose, zur Überwachung und Verlaufsbeobachtung von Prostatakrebs | |
AU2015255160A1 (en) | Urine markers for detection of bladder cancer | |
KR20230119346A (ko) | 흑색종 치료 내성 예측용 trim51 바이오마커 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |